Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.445 AUD | -1.11% |
|
-8.25% | -21.93% |
May. 15 | Imricor Medical Systems, Inc. to Commence 2 Clinical Trials, VISABL-AFL and VISABL-VT | CI |
May. 15 | Transcript : Imricor Medical Systems, Inc. - Shareholder/Analyst Call |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.93% | 59.43M | |
+9.47% | 222B | |
+14.56% | 195B | |
+23.44% | 148B | |
+33.60% | 113B | |
+4.18% | 66.45B | |
+12.90% | 53.11B | |
+3.16% | 50.03B | |
-4.14% | 38.8B | |
-2.34% | 34.85B |
- Stock Market
- Equities
- IMR Stock
- News Imricor Medical Systems, Inc.
- Transcript : Imricor Medical Systems, Inc. - Shareholder/Analyst Call